Overview

Interaction Study SLV337/Simvastatin

Status:
Completed

Trial end date:
2009-07-01

Target enrollment:

Participant gender:

Summary

To investigate the effect of multiple doses of SLV337 on the pharmacokinetics of simvastatin and simvastatin acid when co-administered in healthy male subjects

Phase:

Phase 1

Details

Lead Sponsor:

Solvay Pharmaceuticals

Treatments:

Simvastatin